Author:
Jeong Ji-Cheon,Lee Jae-Wook,Yoon Cheol-Ho,Lee Young-Choon,Chung Kang-Hyun,Kim Min-Gon,Kim Cheorl-Ho
Subject
Drug Discovery,Pharmacology
Reference28 articles.
1. A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss;Agnusdei;Calcified Tissue International,1997
2. Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of Drynaria fortunei on MCF-7 and osteoblastic cells;Chang;Archives of Pharmacal Research,2003
3. Chung, C.H., 2002. Anti-bone resorptive effects of Korean medicine, Drynaria fortunei. Ph.D. thesis, Dongguk University Graduate School, Kyungju, Korea.
4. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium;Ettinger;Annals of Internal Medicine,1987
5. Estrogens in the prevention of osteoporosis in postmenopausal women;Genant;American Journal of Obstetrics and Gynecology,1989
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献